IJMIX
Price
$16.49
Change
-$0.15 (-0.90%)
Updated
Jul 7 closing price
Net Assets
249.12M
JVMTX
Price
$28.94
Change
-$0.22 (-0.75%)
Updated
Jul 7 closing price
Net Assets
22.61B
Interact to see
Advertisement

IJMIX vs JVMTX

Header iconIJMIX vs JVMTX Comparison
Open Charts IJMIX vs JVMTXBanner chart's image
VY® JPMorgan Mid Cap Value I
Price$16.49
Change-$0.15 (-0.90%)
VolumeN/A
Net Assets249.12M
JHancock Disciplined Value Mid Cap R4
Price$28.94
Change-$0.22 (-0.75%)
VolumeN/A
Net Assets22.61B
IJMIX vs JVMTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IJMIX vs. JVMTX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IJMIX is a Buy and JVMTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 22.6B vs. IJMIX (249M). IJMIX pays higher dividends than JVMTX: IJMIX (1.02) vs JVMTX (0.65). IJMIX was incepted earlier than JVMTX: IJMIX (23 years) vs JVMTX (12 years). JVMTX (1.11) is less costly to investors than IJMIX (1.00). JVMTX is a more actively managed with annual turnover of: 49.00 vs. IJMIX (25.00). IJMIX (0) and JVMTX (0) have matching initial minimum investment requirements. IJMIX annual gain was more profitable for investors over the last year : 7.51 vs. JVMTX (3.90). JVMTX return over 5 years is better than : 63.75 vs. IJMIX (23.78).
IJMIXJVMTXIJMIX / JVMTX
Total Expense Ratio0.851.0085%
Annual Report Gross Expense Ratio1.001.1190%
Fund Existence23 years12 years-
Gain YTD1.7278.36121%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets249M22.6B1%
Annual Yield % from dividends1.020.65157%
Returns for 1 year7.513.90193%
Returns for 3 years-2.4023.16-10%
Returns for 5 years23.7863.7537%
Returns for 10 years-21.3146.54-46%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMCX21.60N/A
N/A
Goldman Sachs Emerging Markets Eq C
LINCX20.01N/A
N/A
Lord Abbett International Opp C
TWUIX103.23N/A
N/A
American Century Ultra® I
BSVSX16.31N/A
N/A
Baird Equity Opportunity Investor
TROCX30.97N/A
N/A
Touchstone Non-US Equity I